Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
No immediate changes to diabetes management; leaves open targeted anti-inflammatory interventions in cardiometabolic disease.
Kathryn E. Wellen (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: